article thumbnail

Sana Biotechnology will cut 15% of its workforce in latest layoffs affecting Seattle companies

GeekWire

Seattle-based cell and gene therapy company Sana Biotechnology will reduce its workforce by 15%, according to a statement issued Tuesday. The company said it was shutting a program focused on heart failure and outlined reset priorities for other programs. Data are expected in 2023. Sana CEO Steve Harr. Sana Photo).

article thumbnail

Tech Moves: Adaptive Biotech co-founders join life sciences SPAC; new edtech execs; and more

GeekWire

Chad Robins, left, is co-founder and CEO of Adaptive Biotechnologies, which he co-founded with his brother, Harlan Robins, right, a theoretical physicist turned computational biologist who is the company’s chief scientific officer. Adaptive Biotechnologies Photo). Lance Solomon. based ParentSquare as chief marketing officer.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

GeekWire Awards: How these five Workplace of the Year finalists navigate challenging times

GeekWire

Workplace of the Year finalists, clockwise from top left: Adaptive Biotechnologies co-founders Harlan and Chad Robins; the Helion team; Impinj offices in Seattle; Treasury4 team; Blink CEO Karen Clark Cole. This year’s finalists are Adaptive Biotechnologies, Blink, Helion, Impinj and Treasury4. based data analytics startup.

article thumbnail

Tech Moves: F5 adds CTO and HR chief; Adaptive names CFO; Techstars Seattle leaders depart

GeekWire

Other key personnel changes across the Pacific Northwest tech industry: — Adaptive Biotechnologies named Kyle Piskel as its new chief financial officer. Bryan Copley , CEO and co-founder of Seattle real estate data startup CityBldr , is now a planning commissioner for the City of Redmond. Its stock is up 8% this year. Sarah Studer.

article thumbnail

Seattle startup Truveta raises $95M for ambitious vision to aggregate data across healthcare systems

GeekWire

Seattle-based health data company Truveta today announced $95 million in fresh funding and the addition of three new participating healthcare systems, bringing its total to 17. Truveta last year began an ambitious mission to aggregate medical records data from its partner institutions to link treatments with outcomes and underlying health.

article thumbnail

Absci’s IPO reflects booming biotech market and growing PNW life sciences industry

GeekWire

Absci is the latest in a string of Washington state biotech startups to test the public markets — others including Impel Neuropharma, Sana Biotechnology, Athira Pharma, and Silverback Therapeutics have had IPOs in the past year. The amount of investment that is pouring into biotechnology and the life sciences is incredible,” said Alexandre.

article thumbnail

Don’t spin out too early, and get out of the way: Advice for biotech founders from Dr. Jim Olson

GeekWire

There’s a fourth biotech company being born, said Olson, who also heads the Invent at Seattle Children’s Postdoctoral Scholars Program to train students underrepresented in science for careers in biotechnology. Investors don’t have a tolerance for paying for research, but they don’t mind paying for development.